Lonza Group Ltd (OTCPK:LZAGF)
$ 579 -20.02 (-3.34%) Market Cap: 42.12 Bil Enterprise Value: 43.73 Bil PE Ratio: 59.59 PB Ratio: 4.04 GF Score: 91/100

Lonza Group AG at JPMorgan Healthcare Conference Transcript

Jan 10, 2024 / 12:30AM GMT
Release Date Price: $422.35 (+1.59%)
Richard Vosser
JPMorgan Chase & Co, Research Division - Senior Analyst

Welcome to the Lonza presentation at the 42nd JPMorgan Healthcare Conference. I'm Richard Vosser, European pharma analyst at JPMorgan. It's my great pleasure to introduce the CFO of Lonza, Philippe Deecke, who will give the presentation. After that, there will be a Q&A period. (Operator Instructions).

Philippe, welcome to the conference.

Philippe Deecke
Lonza Group AG - CFO

Thank you very much, Richard. Good afternoon, everyone. Great to see so many people joining us for the Lonza session, and great to be back at JPM to kickstart the year.

So we have about 40 minutes. I need to get that to work. So we have about 40 minutes together. So I will start by sharing an overview of our business and some insight into our unique position within the CDMO industry and why we believe we are well set up to capture the growth and value of this industry. We'll follow this by a closer look at our key priorities and divisional strategies and the attractive portfolio of organic

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot